Semaglutide

$ 1,000

Type: GLP-1 receptor agonist peptide
Composition:
31-amino-acid peptide
Fatty acid side chain (C18) attached via spacer
Modification Purpose: Extends half-life by albumin binding

Certificate of Analysis – Semaglutide

What is Semaglutide?

Semaglutide is a synthetic peptide analog of glucagon-like peptide-1 (GLP-1), a naturally occurring incretin hormone involved in blood glucose regulation and appetite control. Originally developed for the management of type 2 diabetes and obesity in clinical contexts, Semaglutide has become a key focus of research investigating metabolic disorders, insulin sensitivity, and weight regulation. It is notable for its long half-life and strong receptor affinity, making it ideal for studying sustained GLP-1 receptor activity.

Mechanism of Action

Semaglutide acts as a GLP-1 receptor agonist, mimicking the activity of endogenous GLP-1. It stimulates insulin secretion in a glucose-dependent manner, suppresses glucagon secretion, delays gastric emptying, and reduces appetite. These mechanisms contribute to better glycemic control and reduced food intake in animal models. Its prolonged activity is due to structural modifications that resist degradation by dipeptidyl peptidase-4 (DPP-4), the enzyme that rapidly breaks down natural GLP-1.

Solely for laboratory research purposes only. Not intended for human consumption.

Safety Profile

Semaglutide has been studied extensively in both preclinical and clinical settings and is generally well tolerated. In laboratory models, common side effects include transient gastrointestinal symptoms such as nausea or decreased appetite. Long-term studies have not shown significant systemic toxicity at research doses. Nonetheless, as with all peptides, proper handling and storage are essential for maintaining stability and minimizing degradation.

Solely for laboratory research purposes only. Not intended for human consumption.

Key Studies

Animal models of type 2 diabetes and obesity have shown improvements in weight reduction, insulin sensitivity, and lipid profiles following Semaglutide administration.
Research in appetite regulation and hypothalamic signaling has revealed insights into central GLP-1 pathways and food-related behavior.
Studies continue to explore potential cardiovascular and neuroprotective benefits, especially in models of metabolic syndrome and cognitive decline.

Solely for laboratory research purposes only. Not intended for human consumption.

Conclusion

Semaglutide is a powerful peptide for laboratories focused on metabolic research, particularly in the areas of glucose control, appetite regulation, and energy homeostasis. Its extended activity and multifaceted effects make it a valuable tool for understanding the broader role of GLP-1 signaling in physiology. Semaglutide is for research use only and is not intended for human consumption or therapeutic application.

Solely for laboratory research purposes only. Not intended for human consumption.